Crdentia Announces 2007 Fourth Quart...(al results that the Companyachieves may ...),Health
Navigation Links
Crdentia Announces 2007 Fourth Quarter Results
Date:4/1/2008
al results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. Crdentia undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
Contacts
Crdentia Corp.
John Kaiser, CEO
Phone: 972.850.0780
Fax: 972.392.2722
Jim TerBeest, CFO
Phone: 972.850.0780
Fax: 972.392.2722
Crdentia Corp.
Unaudited Consolidated Statements of Operations
Three Months Ended
December 31,
2007 2006
Revenue from services $9,806,540 $8,531,970
Direct operating expenses 7,578,479 6,912,624
Gross profit 2,228,061 1,619,346
Operating expenses:
Selling, general, and
administrative expenses 4,305,809 3,924,497
Loss on impairment of intangibles - 10,000,000
Gain from settlement of claims 80,706 100,075
Gain from extinguishment of debt - 524,213
Total operating expenses 4,386,515 14,548,785
Loss from continuing operations
before interest and taxes (2,158,454) (12,929,439)
Interest expense, net (486,415) (817,050)
Loss from continuing operations
before income taxes (2,644,869) (13,746,489)
Income tax expense
'/>"/>
| SOURCE Crdentia Corp. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Wasserman Morris Initiates Research Coverage on Crdentia
2. Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer
3. Crdentia Selected by Leading Staffing Vendor to Provide Health Care Staffing Services to One of the Largest Hospital Chains in the U.S.
4. Crdentia Announces Completion of $10.2 Million Long-Term Debt Financing
5. Investor Insight Initiates Analyst Coverage on Crdentia
6. Crdentia Promotes Kevin Bollin to Area Manager of Austin, Dallas and San Antonio, Texas, Markets
7. Crdentia Appoints Charlie Mayhone to Director of Operations for its National Travel Division and Charlotte, North Carolina Market
8. Crdentia Appoints Debbie Griffith to Director of Business Development, Reporting Directly to CEO
9. Crdentia Announces Promotion of Penny Kirsch to Vice President of Human Resources
10. Crdentia Announces Appointment of Tim Jones to Senior Management Team
11. Crdentia Announces Completion of $5M Financing
Post Your Comments:
(Date:7/23/2008)...in harmless moles, may be key to diagnosis , ...lanoma produces high levels of a protein called IM..., University of Rochester Medical Center researche...ctors a new way to distinguish melanoma -- the mos...es that look like melanoma. , The study was pub...
(Date:7/23/2008)...wire-USNewswire/ -- The American Heart,Association...Lewis,Achievement Award, the association,s highest...rd was established in 2000, to recognize and honor...dical journalists who have documented,the consider...ase and,stroke. This career achievement award was ...
(Date:7/23/2008)...3 /PRNewswire-USNewswire/ -- The Alameda County,Pl...y 24-26 at the Oakland,Marriott to address the soc...n individuals from low-income and communities of c... and counties will attend. Place Matters,is a nati...and Economic,Studies, Health Policy Institute and ...
(Date:7/23/2008)... Dangerous for Morbidly Obese Women? ,As the o...re consulting plastic surgeons for breast reductio...d been thought to have higher complication rates. ... as safe to perform large-volume breast reductions...tudy title: Breast Reduction: Safe in the Morbidly...
Breaking Medicine News(10 mins):Health News:Protein Gives Doctors New Tool to Detect Melanoma 2Health News:Alameda County Hosts National Initiative to Reduce Health Disparities 2... come up with a bill seeking direct control over a... centres in the state, State Health Minister Digam...roduce a special bill in the next assembly session...perating in the state. This is to check activities...
...that folic acid supplements can help to prevent ca...//. Published in the July 15, 2006 issue of CANC...oom), a peer-reviewed journal of the American Canc...1 of 43 patients with the precancerous laryngeal l...
...rogrammer flew in to Boston from India, on April 2...ervices company headquartered //in the 18th floor ...ze that a potential measles outbreak loomed before...toms of measles such as rash, fever, cough began t...
...t a new report looked at new prescription- only m...d 2006 //. In the last six years, 78 new prescri...alian PBS, which was the equivalent of Pharmac. O...stered in New Zealand, of which only 20 are funde...
Other Medicine News:Health News:Folic Acid Supplements to Prevent Cancer 2Health News:Global Threat of Measles Outbreak 2(Date:7/22/2008)...APOLIS, July 22 /- Nonin Medical, a l...ions for more than 20 years, has entered,the clini... to measure,regional oxygen saturation. Today,s mo...ontinuous monitoring of the regional blood oxygena...sting data and outcomes from an ongoing clinical s...
(Date:7/22/2008)...Demonstrates Feasibility and Efficacy of Treating ...er Cancer, SAN FRANCISCO, and YONGIN-SI, South Ko...rancisco, CA and Ottawa, Ontario), and its South,K...hat novel findings from,a Phase I clinical trial o...ted that the product was well-tolerated and result...
(Date:7/22/2008)...offrey Allan Will Stress the Importance to Patient...s Approval Pathway, RICHMOND, Va., July 22 /PRNew...a developer of follow-on biologics and biopharmace...., CEO of Insmed, will present at a,Congressional ...,significant need for establishing an approval pat...
(Date:7/22/2008)...loped and Validated by Columbia University Medical...ietary MicroRNA Technology, The Test Differentia... Cancer (NSCLC), Classifying Squamous-Cell Carcin...ent and Specificity of 90 Percent,This is the Firs...nsitivity as Biomarkers for Accurate Diag...
Breaking Medicine Technology:Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5First Lady Honors Women at International Womens Day Event 13817 1First Lady Honors Women at International Womens Day Event 13817 2Advanced Life Sciences Receives Nasdaq Notification 3796 1Advanced Life Sciences Receives Nasdaq Notification 3796 2Advanced Life Sciences Receives Nasdaq Notification 3796 3Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 13812 1Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 13812 2Researchers Design Promising Cancer Drug 13810 1Researchers Design Promising Cancer Drug 13810 2[0] Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market[0] Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus[0] Insmed CEO to Present at Congressional Briefing on Follow-On Biologics[1] First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
...tient Lung Cancer Diversity Study, CHICAGO, June 0...lung cancer is the leading cause of cancer death i...d to be diagnosed,and 16,700 deaths expected this ...eading cause of cancer death in Hispanic men and t...c women.(ii),Researchers at Eli Lilly and Company ...
...ual Meeting of the American Society of,Clinical On...ciClone Pharmaceuticals,Inc. (Nasdaq:SCLN) and Si... product candidate thymalfasin (ZADAXIN(r), thymos...se 2 clinical trial,treating patients diagnosed wi...form of skin cancer. Results showed that thymalfas...
Other Medicine Technology:Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 2Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 3Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 4Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 5Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 6Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 7Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 8Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 9Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 10Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 11Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Gradua
Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Graduat
Laser resistant tubes for use with CO2 and KTP Lasers., ,Designed for airway management during laser surgery of the larynx or other areas in close proximity to the trachea.
For MicroLaryngeal Tracheal Surgery
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |